Liquidia soars over 40% after agreeing to pay $380.7 million to settle with United Therapeutics and keep YUTREPIA on the market

SentiSense · Published · Updated

Liquidia shares jumped more than 40% after hours after it settled all pending litigation with United Therapeutics. Liquidia will pay a total of $380.7...

Sign in to read the full story. Free accounts include 20 full reads a month.

Sign in or create a free account

Powered by SentiSense - Intelligent Market Analysis